WallStreetZenWallStreetZen

NASDAQ: ENLV
Enlivex Therapeutics Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ENLV earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$27.2M
Current Profit Margin
0%

ENLV Return on Equity

Current Company
-57%
Current Industry
15.6%
Current Market
-8.4%
ENLV's Return on Equity (-57%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ENLV announces earnings.

ENLV Return on Assets

Current Company
-47.7%
Current Industry
2.2%
ENLV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ENLV Return on Capital Employed

Current Company
-63.77%
Current Industry
17.7%
ENLV's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ENLV vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ENLV$0.00-$26.31M-$27.16MN/AN/A
SLGL$1.67MN/A-$27.73M+40.42%N/A
CLRB$0.00-$37.58M-$37.75MN/AN/A
FIXX$1.96M-$128.94M-$131.14M-13.85%N/A
NLTX$0.00-$32.25M-$34.26M-100.00%N/A
View Top Biotech Stocks

ENLV earnings dates

Next earnings date
Dec 15, 2023

Enlivex Therapeutics Earnings & Revenue FAQ

What were ENLV's earnings last quarter?

On Invalid Date, Enlivex Therapeutics (NASDAQ: ENLV) reported Q3 2023 earnings per share (EPS) of -$0.32, up 3.23% year over year. Total Enlivex Therapeutics earnings for the quarter were -$5.96 million. In the same quarter last year, Enlivex Therapeutics's earnings per share (EPS) was -$0.31.

If you're new to stock investing, here's how to buy Enlivex Therapeutics stock.

What was ENLV's earnings growth in the past year?

As of Q4 2023, Enlivex Therapeutics's earnings has grown year over year. Enlivex Therapeutics's earnings in the past year totalled -$27.16 million.

What is ENLV's earnings date?

Enlivex Therapeutics's earnings date is Invalid Date. Add ENLV to your watchlist to be reminded of ENLV's next earnings announcement.

What was ENLV's revenue last quarter?

On Invalid Date, Enlivex Therapeutics (NASDAQ: ENLV) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Enlivex Therapeutics's revenue was $0.00.

What was ENLV's revenue growth in the past year?

As of Q4 2023, Enlivex Therapeutics's revenue has grown null year over year. Enlivex Therapeutics's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.